Any current/future new fundraising through debt or equity?

The company currently has zero long-term debt. They have working capital facilities with an undrawn drawing power of approximately Rs. 60-75 crores. They can withdraw Rs. 60-75 crores from working capital and can raise an additional Rs. 175 crores if needed, totaling up to Rs. 250 crores. Money is not a problem for them, indicating capacity for raising funds if required. However, there is no specific mention of an immediate or planned fundraising through debt or equity. Focus currently is on optimizing manufacturing costs and operational efficiency before proceeding with new projects.

Any current/future capex/capital investment/strategic investment?

The company has completed designing and obtained all permissions for new equipment. Financial resources are available and include zero long-term debt; working capital and potential borrowing capacity up to Rs. 250 crores are accessible. The next step is to place orders for the new equipment once manufacturing cost and yields are confidently optimized. Plant setup timeline is estimated at 1 to 1.5 to 2 years. After plant commissioning, it will take around 1.5 years for the product to complete the approval cycle. Full capacity operations are expected within approximately three years after the fi

Future growth expectations in sales/revenue/volumes?

Management anticipates revenue to substantially grow with the commercialization of new high-value products, including isostearic acid and another new product with 40,000 MT capacity that could potentially double current sales. Isostearic acid is expected to ramp up gradually, with approvals and marketing ongoing; full capacity utilization and significant export volumes projected within 2-3 years. The new product commercialization is targeted within FY26, with plant installation completed and production costs/yields being optimized. Market entry for these products will be gradual due to high pr

Future growth expectations in earnings/operating earnings/profits/EPS?

Isostearic acid, a high-value, value-added product, is expected to significantly boost margins and revenues starting from April 2025. Company expects EBITDA margins to improve to around 12%-15% from April 2025 onwards due to ramp-up of isostearic acid sales. New product capacity of 40,000 tons, once commercialized, is expected to double the current sales on a high-value product basis. Full utilization of new product capacity and isostearic acid ramp-up projected over 1.5-3 years, with commercial production starting potentially by FY26. Operating profits and EPS expected to improve as import du

Current/ Expected Orderbook/ Pending Orders?

The company has completed designing and obtained all necessary permissions for the new project. Funding is in place; money is available for project execution. The order placement for equipment is pending until the company is confident about manufacturing costs and yields. Once confident, project implementation will take approximately 1 to 1.5-2 years. After plant commissioning, the product will require about one cycle, and full capacity operation is expected within approximately 3 years from the decision to proceed. No specific current orderbook or pending orders quantity is disclosed, as the

IN US

Sale is live|00:00:00left today

Fairchem Organics LtdQ4 FY26Chemicals & Petrochemicals

Fairchem Organics Ltd Q4 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹635P/E: 129.9Market Cap: ₹807 CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 2

Margin

Category 1

Fundraise

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 2

→Management anticipates revenue to substantially grow with the commercialization of new high-value products, including isostearic acid and another new product with 40,000 MT capacity that could potentially double current sales.
→Isostearic acid is expected to ramp up gradually, with approvals and marketing ongoing; full capacity utilization and significant export volumes projected within 2-3 years.
→The new product commercialization is targeted within FY26, with plant installation completed and production costs/yields being optimized.
→Market entry for these products will be gradual due to high product quality standards and long approval cycles, especially for export markets in cosmetics, pharmaceuticals, and biodegradable lubricants.
→Domestic and export demand for isostearic acid is growing, with exports constituting nearly 90-100% of sales.
→EBITDA margins are expected to improve to 12%-15% from FY26 due to higher contribution from value-added products and normalization of raw material duties.
→Capacity expansion plans will only be considered after achieving full utilization of existing plants.

Margin guidance

Category 1

→Isostearic acid, a high-value, value-added product, is expected to significantly boost margins and revenues starting from April 2025.
→Company expects EBITDA margins to improve to around 12%-15% from April 2025 onwards due to ramp-up of isostearic acid sales.
→New product capacity of 40,000 tons, once commercialized, is expected to double the current sales on a high-value product basis.
→Full utilization of new product capacity and isostearic acid ramp-up projected over 1.5-3 years, with commercial production starting potentially by FY26.
→Operating profits and EPS expected to improve as import duty issues resolve and paint sector demand revives.
→Export share, especially of isostearic acid, is increasing, boosting profitability further.
→Management anticipates reaching full capacity and steady state in around 3 years post project initiation, leading to sustained earnings growth.

3 more insights locked — sign up free to unlock

Fundraise plans

→The company currently has zero long-term debt.
→They have working capital facilities with an undrawn drawing power of approximately Rs. 60-75 crores.
→They can withdraw Rs. 60-75 crores from working capital and can raise an additional Rs. 175 crores if needed, totaling up to Rs. 250 crores.
→Money is not a problem for them, indicating capacity for raising funds if required.
→However, there is no specific mention of an immediate or planned fundraising through debt or equity.
→Focus currently is on optimizing manufacturing costs and operational efficiency before proceeding with new projects.

Order book

→The company has completed designing and obtained all necessary permissions for the new project.
→Funding is in place; money is available for project execution.
→The order placement for equipment is pending until the company is confident about manufacturing costs and yields.
→Once confident, project implementation will take approximately 1 to 1.5-2 years.
→After plant commissioning, the product will require about one cycle, and full capacity operation is expected within approximately 3 years from the decision to proceed.
→No specific current orderbook or pending orders quantity is disclosed, as the focus is on readiness to scale after cost optimization.

Capex plans

Yes

→The company has completed designing and obtained all permissions for new equipment.
→Financial resources are available and include zero long-term debt; working capital and potential borrowing capacity up to Rs. 250 crores are accessible.
→The next step is to place orders for the new equipment once manufacturing cost and yields are confidently optimized.
→Plant setup timeline is estimated at 1 to 1.5 to 2 years.
→After plant commissioning, it will take around 1.5 years for the product to complete the approval cycle.
→Full capacity operations are expected within approximately three years after the final decision to proceed.
→The approach is cautious to avoid massive cash losses from incorrect yields or cost issues.
→No immediate plans to expand beyond achieving full capacity utilization in the near term.

How does Fairchem Organics Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

1Fairchem Organics Ltd

Rev 2Mar 1

See full Chemicals & Petrochemicals sector rankings

Want more stocks like Fairchem Organics Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio